The Pharmaceutical Market: Ukraine

Date: January 31, 2013
Pages: 100
Price:
US$ 1,295.00
License [?]:
Publisher: Espicom Business Intelligence
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: PC109CFC8CBEN
Leaflet:

Download PDF Leaflet

The Pharmaceutical Market: Ukraine
OVERVIEW OF THE PHARMACEUTICAL MARKET IN UKRAINE

Foreign and domestic drugmakers in Ukraine will see their operating margins squeezed from2013as the Ministry of Health introduces more severe limitson mark-ups. Combined with the likely devaluation of the hryvnia, these factors represent a very large business risk for international drugmakers operating in the country. While Ukraine remains one of Central and Eastern Europe (CEE)'s more promising pharmaceutical markets given its favourable demographics and disease profile, its chronic lack of economic and political stability remains a critical impediment to fulfilling this potential.

Headline Expenditure Projections

Pharmaceuticals: UAH26.75bn (US$3.35bn) in 2011 to UAH30.79bn (US$3.75bn) in 2012; +15.1% in local currency terms and +12.1% in US dollar terms. Forecast unchanged from Q4 12.

Healthcare: UAH96.98bn (US$12.14bn) in 2011 to UAH109.66bn (US$13.37bn) in 2012; +13.1% in local currency terms and +10.1% in US dollar terms. Forecast slightly up from Q4 12 on account of new historical figures.

Medical devices: UAH6.38bn (US$799mn) in 2011 to UAH7.39bn (US$901mn) in 2012; +15.8% in local currency terms and +12.8% in US dollar terms. Forecast slightly up from Q4 12 on account of new historical figures.

Competitive Landscape

The Competitive Landscape section provides comparative company analyses and rankings by US$ sales and % share of total sales - for the total pharmaceutical sector, as well as the OTC, generics, and distribution sub-sectors.
EXECUTIVE SUMMARY

SWOT ANALYSIS

    Ukraine Pharmaceutical And Healthcare Industry SWOT
    Ukraine Political SWOT
    Ukraine Economic SWOT
    Ukraine Business Environment SWOT

PHARMACEUTICAL RISK/REWARD RATINGS

    Table: Emerging Europe – Regional Pharmaceutical Risk/Reward Ratings, Q113
    Rewards
    Risks

MARKET OVERVIEW

REGULATORY REGIME

    Recent Regulatory Amendments
    Pharmaceutical Advertising
    Intellectual Property Issues
    Counterfeit Drugs
    Pricing Regime
    Recent Pricing Regime Developments
    Reimbursement Regime
    Drug Tendering Regime

INDUSTRY DEVELOPMENTS

    Epidemiology
    Table: Selected Causes of Death, 2005-2010 (000's)
    Table: Morbidity by Selected Diseases, 2005-2010 (000's)
    Public Health Developments
    Healthcare System
    Healthcare Funding
    Healthcare System Reform
    Health Insurance Developments
    Healthcare Provision
    Table: Number of Outpatient Facilities, 1995-2010
    Research and Development (R&D)
    Clinical Trials
    Medical Devices

INDUSTRY FORECAST SCENARIO

    Pharmaceutical Market Forecast
    Table: Pharmaceutical Sales, Historical Data and Forecasts
    Healthcare Market Forecast
    Table: Healthcare Expenditure Trends, Historical Data and Forecasts
    Table: Government Healthcare Expenditure Trends, Historical Data and Forecasts
    Table: Private Healthcare Expenditure Trends, Historical Data and Forecasts
    Key Growth Factors – Macroeconomic
    Prescription Drug Market Forecast
    Table: Ukraine Prescription Drug Market Indicators, Historical Data and Forecasts
    Patented Drug Market Forecast
    Table: Patented Drug Market Indicators, Historical Data and Forecasts
    Generic Drug Market Forecast
    Table: Generics Drug Market Indicators, Historical Data and Forecasts
    OTC Medicine Market Forecast
    Table: OTC Medicine Market Indicators, Historical Data and Forecasts
    Pharmaceutical Trade Forecast
    Table: Pharmaceutical Trade Data And Forecasts (US$mn)
    Table: Pharmaceutical Trade Data And Forecasts (UAHmn)
    Medical Device Market Forecast
    Table: Medical Device Market Indicators, Historical Data and Forecasts
    Other Healthcare Data
    Key Risks to Forecasts

COMPETITIVE LANDSCAPE

    Pharmaceutical Industry
    Table: Retail Pharmacy Sales Value & Volume, 2004-2010 (Million)
    Table: Retail Pharmacy Sales Value by Leading Company, 2007-2010 (UAH Million)
    Table: Retail Pharmacy Sales Value & Volume by Origin, 2010 (Million)
    Table: Retail Pharmacy Sales Volume by Leading Company, 2010 (Million)
    Domestic Pharmaceutical Sector
    Foreign Pharmaceutical Sector
    Table: Association of International Manufacturers (AIPM) Ukraine Members, 2011
    Recent Company Activities
    Pharmaceutical Wholesale
    Pharmaceutical Retail

COMPANY PROFILES

    Arterium
    Gedeon Richter
    Krka
    Lek (Novartis/Sandoz)
    Table: Ukraine's Population By Age Group, 1990-2020 ('000)
    Table: Ukraine's Population By Age Group, 1990-2020 (% of total)
    Table: Ukraine's Key Population Ratios, 1990-2020
    Table: Ukraine's Rural And Urban Population, 1990-2020

GLOSSARY

BMI METHODOLOGY

    How We Generate Our Pharmaceutical Industry Forecasts
    Pharmaceuticals Risk/Reward Ratings Methodology
    Ratings Overview
    Table: Pharmaceutical Risk/Reward Ratings Indicators
    Weighting
    Table: Weighting Of Components
    Sources
Skip to top


The Pharmaceutical Market: Germany US$ 1,295.00 Jan, 2013 · 112 pages
The Pharmaceutical Market: Hungary US$ 1,295.00 Jan, 2013 · 95 pages
The Pharmaceutical Market: India US$ 1,295.00 Jan, 2013 · 117 pages

Ask Your Question

The Pharmaceutical Market: Ukraine
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: